XBiotech
Share
True Human™ antibodies harness natural immunity and allow us to share the best of natural immunity for all. At XBiotech we are rethinking the way medicines are discovered and commercialized—from pioneering ways to create safer drugs that harness our natural immunity to disease, to developing technology that enables rapid transition from discovery to large-scale manufacturing.
03/06/2026
XBiotech Awarded Three U.S. Patents Protecting Next-Generation True Human™ Antibodies Targeting Interleukin-1 Alpha
XBiotech Awarded Three U.S. Patents Protecting Next-Generation True Human™ Antibodies Targeting Interleukin-1 Alpha | XBiotech XBiotech is conducting a Phase I study to evaluate the safety and pharmacokinetics of its stroke therapy candidate, Hutrukin, in healthy volunteers.
02/04/2026
https://www.xbiotech.com/news/advancing-infectious-disease-innovation
Advancing Infectious Disease Innovation: New Microscopy Insights from Our UT Austin Collaboration | XBiotech XBiotech is conducting a Phase I study to evaluate the safety and pharmacokinetics of its stroke therapy candidate, Hutrukin, in healthy volunteers.
XBiotech Pauses Rheumatology program
https://investors.xbiotech.com/news-releases/news-release-details/xbiotech-pauses-rheumatology-program
01/04/2024
XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus | XBiotech AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIRE) -- XBiotech Inc. today announced that it plans to expand it’s campus headquarters with the construction of a new, state-of-the-art research and development facility. XBiotech has received City of Austin approval to begin excavation for site preparation
Click here to claim your Sponsored Listing.
Category
Website
Address
5217 Winnebago Lane
Austin, TX
78744
Opening Hours
| Monday | 9am - 5pm |
| Tuesday | 9am - 5pm |
| Wednesday | 9am - 5pm |
| Thursday | 9am - 5pm |
| Friday | 9am - 5pm |
